Where is Cellectar Biosciences's headquarters?

Cellectar Biosciences is located in Madison, Wisconsin, United States.

Who invested in Cellectar Biosciences?

Cellectar Biosciences has 17 investors including Caligan Partners And Stonepine Capital Management.

When was the last funding round for Cellectar Biosciences?

Cellectar Biosciences closed its last funding round on obfuscated from a Post-IPO Equity round.

Who are Cellectar Biosciences's competitors?

Alternatives and possible competitors to Cellectar Biosciences may include Avenzo Therapeutics, Calidi Biotherapeutics, And Aura Biosciences.

How much funding has Cellectar Biosciences raised to date?

Cellectar Biosciences has raised obfuscated.

Cellectar Biosciences - Financial Details

Financial Details

Highlights

Cellectar Biosciences

is registered under the ticker

NASDAQ:CLRB

Cellectar Biosciences

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Post-IPO Equity

round.

Cellectar Biosciences

is funded by

investors.

Caligan Partners

and

Stonepine Capital Management

are the most recent investors.

Cellectar Biosciences

has acquired

Novelos Therapeutics

obfuscation

. They acquired

Novelos Therapeutics

for

obfuscation

Stock Symbol

NASDAQ:CLRB

Funding Rounds

Total Funding Amount

obfuscation

Lead Investors

Investors

IPO & Stock Price

Stock Symbol

NASDAQ:CLRB

IPO Date

obfuscation

Cellectar Biosciences

is registered under the ticker

NASDAQ:CLRB

Funding Rounds

Number of Funding Rounds

Total Funding Amount

obfuscation

Cellectar Biosciences

has raised a total of

obfuscation

in funding over

rounds. Their latest funding was raised on

obfuscation

from a

Post-IPO Equity

round.

Which funding types raised the most money?

How much funding has this organization raised over time?

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Cellectar Biosciences	8	obfuscated obfuscation	Nantahala Capital Management	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Cellectar Biosciences	8	obfuscated obfuscation	Nantahala Capital Management	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Cellectar Biosciences	8	obfuscated obfuscation	Nantahala Capital Management	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Cellectar Biosciences	8	obfuscated obfuscation	Nantahala Capital Management	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Cellectar Biosciences	8	obfuscated obfuscation	Nantahala Capital Management	Post-IPO Equity

Investors

Number of Lead Investors

Number of Investors

Cellectar Biosciences

is funded by

investors.

Caligan Partners

and

Stonepine Capital Management

are the most recent investors.

Which investors participated in the most funding rounds?

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Caligan Partners	—	Post-IPO Equity - Cellectar Biosciences	—
Caligan Partners	—	Post-IPO Equity - Cellectar Biosciences	—
Caligan Partners	—	Post-IPO Equity - Cellectar Biosciences	—
Caligan Partners	—	Post-IPO Equity - Cellectar Biosciences	—
Caligan Partners	—	Post-IPO Equity - Cellectar Biosciences	—

Acquisitions

Number of Acquisitions

Cellectar Biosciences

has acquired

Novelos Therapeutics

obfuscation

. They acquired

Novelos Therapeutics

for

obfuscation

Which types of acquisition does this organization make most frequently?

Acquiree Name	Announced Date	Price	Transaction Name
Novelos Therapeutics	obfuscated obfuscation	obfuscated obfuscation	Novelos Therapeutics acquired by Cellectar Biosciences